Charles River Laboratories CRL Debt Issuance Proceeds
Debt Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfLongTermDebt.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's debt issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's debt issuance proceeds?
- Charles River Laboratories (CRL) reported debt issuance proceeds of $912.46M in Q1 2026.
- How has Charles River Laboratories's debt issuance proceeds changed year-over-year?
- Charles River Laboratories's debt issuance proceeds increased by 119.2% year-over-year, from $416.34M to $912.46M.
- What is the long-term trend for Charles River Laboratories's debt issuance proceeds?
- Over 4 years (2021 to 2025), Charles River Laboratories's debt issuance proceeds has grown at a -35.2% compound annual growth rate (CAGR), from $6.95B to $1.23B.
- What does debt issuance proceeds mean?
- Cash raised by borrowing money through debt instruments.
- How do you interpret debt issuance proceeds?
- Higher values suggest increased leverage or a need for liquidity, while lower values may indicate sufficient internal cash flow or restricted access to credit.
- How does debt issuance proceeds compare across companies?
- Depends on the company's capital structure and interest rate environment.